5 Companies Trending Now (open)

Tickers Inside Dear Reader, According to our research, there are a few trending companies that have recently received buy ratings and showing a combination of positive investor sentiment, news headlines and blog buzz. With that said, we are not recommending buying these names but we are adding them to our stock watchlist. We will continue to monitor companies to see if the momentum continues. --------------------------------------------------------------- Sponsor [Stopping Bad Guys an Investor's Dream]( shootings are up 66% since 2019. Ghost/3D printed guns, plastic knives, explosives, bombs of all varieties, and more can move easily undetected by our outdated technology. But now, newly developed millimeter-wave technology safely & quickly scans for metallic and non-metallic weapons -- and will soon move from beta testing to commercial use. [See How Early Stage Investors Could Benefit]( --------------------------------------------------------------- [Arrowhead Pharmaceuticals, ARWR]( Summary: Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Joel Beatty analyst at Robert W. Baird reiterates coverage on [Arrowhead Pharmaceuticals (ARWR)]( with a Buy rating and has set a price target of $ 60. [TipRanks.com]( reports that [Arrowhead Pharmaceuticals]( has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $61.11. In addition, TradingView issued a Buy rating for [ARWR]( over the next month, Barchart.com has a hold rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on ARWR, please click here >>]( --------------------------------------------------------------- [Frontline, FRO]( Summary: Frontline plc is a shipping company, engages in the seaborne transportation of crude oil and oil products. It also involved in the charter, purchase and sale of vessels. Frontline plc, formerly known as Frontline Ltd., is based in Hamilton, Bermuda. Amit Mehrotra analyst at Deutsche Bank reiterates coverage on [Frontline (FRO)]( with a Hold rating and has set a price target of $ 16.5. [TipRanks.com]( reports that [Frontline]( has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $17.82. In addition, TradingView issued a n/a (possibly response change) rating for [FRO]( over the next month, Barchart.com has a buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on FRO, please click here >>]( --------------------------------------------------------------- Sponsor [Sell every Stock except ONE]( are down... But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month... [Ticker Revealed.]( --------------------------------------------------------------- [Ashland, ASH]( Summary: Ashland Global Holdings Inc. is a leading specialty chemicals company serving a vast range of consumer and industrial markets including automotive, construction, architectural coatings, adhesives, energy, food & beverage and pharmaceutical. The company has a diverse business portfolio with different value propositions, with respect to the markets served. Ashland has a controlling interest in leading consumer-branded lubricant supplier, Valvoline Inc. Chris Parkinson analyst at Mizuho Securities reiterates coverage on [Ashland (ASH)]( with a Buy rating and has set a price target of $ 141. [TipRanks.com]( reports that [Ashland]( has 8 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $132.38. In addition, TradingView issued a Buy rating for [ASH]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on ASH, please click here >>]( --------------------------------------------------------------- [Customers Bancorp, CUBI]( Summary: Customers Bancorp is a bank holding company of Customers Bank, a state-chartered bank in Pennsylvania. It provides banking services to small and medium-sized businesses, professionals, individuals and families. The company offers depository products, commercial lending products, specialty lending products and consumer lending. Matthew Breese analyst at Stephens reiterates coverage on [Customers Bancorp (CUBI)]( with a Hold rating and has set a price target of $ 45. [TipRanks.com]( reports that [Customers Bancorp]( has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $51.00. In addition, TradingView issued a Neutral rating for [CUBI]( over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Neutral short-term outlook. [For the chart and additional details on CUBI, please click here >>]( --------------------------------------------------------------- Sponsor [Lithium Crisis Is Real And This Is Great News For Investors]( [Read this Special Report to see how investors could take advantage of the lithium crisis]( --------------------------------------------------------------- [Achieve Life Sciences, ACHV]( Summary: Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States. [Francois Brisebois analyst at Oppenheimer reiterates coverage on]( Life Sciences (ACHV)]( with a Buy rating and has set a price target of $ 17. [TipRanks.com]( reports that [Achieve Life Sciences]( has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $21.00. In addition, TradingView issued a Buy rating for [ACHV]( over the next month, Barchart.com has a Weak sell rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on ACHV, please click here >>]( --------------------------------------------------------------- Sponsor [Millionaire Investor Reveals: "How I Made My Second Fortune... By Avoiding 99% of Stocks"]( this small group of unique stocks… never sell them… and make all the money you need… No matter what happens in the market. [Revealed here: the name and ticker of the #1 stock.]( --------------------------------------------------------------- Remember, securities are volatile, so please do your own research. One resource you need to consider using [Tipranks.com]( where as a premium member you get access to all buy ratings, price targets and insider trading signals. [Get more from TipRanks.com here >>]( Thanks for reading! The Editor, [wallstreetanalystpress.com]( --------------------------------------------------------------- Sponsor [Are You Scared Right Now?]( With the market uglier than it has been in over 50 years … you should be. But with people fleeing stocks at record levels, savvy investors are finding stocks at bargain prices. For example, one stock ahead of its class is expected to surge 2,000% in the next five years. [Click here for more details.]( --------------------------------------------------------------- [To Cancel Your Free Subscription, click here.]( WallStreetAnalystPress.com Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to WallStreetAnalystPress. WallStreetAnalystPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy Unit 407 | Mt. Mourne | North Carolina | 28123 [UNSUBSCRIBE](